PAMU
BNTX icon

Pictet Asset Management (UK)’s BioNTech BNTX Stock Holding History

Pictet Asset Management (UK)’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$9.49M Buy
42,389
+22,791
+116% +$4.3M 0.01% 686
2021
Q1 		$2.14M Buy
+19,598
New +$2.08M ﹤0.01% 974

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Pictet Asset Management (UK)'s BNTX Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its BioNTech (BNTX) stake by 116% in Q2 2021, buying an estimated $4.3M and bringing the position to 42,389 shares worth $9.49M. The position accounts for 0.01% of the portfolio, ranked #686.

Pictet Asset Management (UK) first reported a position in BNTX in Q1 2021 and has held it in 2 quarters since. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2021.

  • Pictet Asset Management (UK) held 42,389 shares of BioNTech worth $9.49M as of Q2 2021.
  • Pictet Asset Management (UK) bought 22,791 BioNTech shares in Q2 2021, an estimated $4.3M.
  • BioNTech made up 0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #686 holding.
  • Pictet Asset Management (UK) first reported a position in BioNTech in Q1 2021 and has held it in 2 quarters since.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.